Clinical Trial Update: Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies [Phase 1]

View source ↗

Summary

This update covers a Phase 1 trial of anti-third-party donor T lymphocytes with nonmyeloablative stem cell transplantation for indolent lymphoid malignancies. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Donor T lymphocytes (third-party) (T lymphocytes)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 1 | Status: TERMINATED